Concentra Group Holdings Parent, Inc. (NYSE: CON), a leader in occupational health services with a market capitalization of $2.84 billion, has announced preliminary financial results for the fourth ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CON stock, giving a Buy rating yesterday.Invest with Confidence: ...

Nova Biomedical develops and manufactures medical devices and diagnostics equipment that can be used by health-care providers for advanced blood testing and analysis, according to its website.

Concentra as we continued to focus on providing superior outcomes and exceptional experience to our patients and customers. Concentra’s IPO in 2024 was an energizing development followed by two ...